Ed Bisch had never even heard the term “oxy” when his 18-year-old son, Eddie, fatally overdosed from the drug in 2001. Nor did he know he’d spend the next 20-plus years learning everything he could about OxyContin and the company that sells it.

That manufacturer, Purdue Pharma, was recently close to a bankruptcy deal that would have seen billions of dollars go toward lawsuits related to OxyContin and protected the Sackler family, which formerly controlled the company, from personal liability in future civil lawsuits. The U.S. Supreme Court temporarily blocked the agreement on Aug. 10, placing into limbo the $6 billion slated to be distributed to plaintiffs across the country.

Of those billions, $225 million was earmarked for Pennsylvania. The state has already received $1.07 billion in opioid settlement funds from various other lawsuits, including those connected to McKesson, AmerisourceBergen, Cardinal Health and Johnson & Johnson, according to public health nonprofit Vital Strategies. It has settlement money pending from CVS, Walgreens, Walmart and others.

While that places a pot of money meant for addiction support and other resources at least temporarily out of reach, for Mr. Bisch and many others impacted by the opioid epidemic, such worries are trumped by the billionaire Sackler family being granted immunity. He called the bankruptcy filing “a scam.”

Advertise with us

“We weren’t about the money, we wanted accountability,” said Mr. Bisch, founder of Relatives Against Purdue Pharma.

But Purdue Pharma’s $6 billion remains more or less hypothetical, as the Supreme Court won’t hear the Stamford, Conn.-based company’s case until December, and no applications or funding designations had been made before the high court decision. Still, as Pennsylvania receives other opioid settlement money, more immediate questions remain about how existing funds are being prioritized.

The Purdue Pharma headquarters are in Stamford, Conn.(AP)

The national opioid settlement fund recently topped $54 billion. States, however, don’t handle in a uniform way the public reporting of how settlement money is spent, in some cases shielding public knowledge of where funds are going — and whether they are being spent the way officials say they are.

A few states — North Carolina was the latest — have committed to publicly reporting 100% of funding they receive from opioid settlements and where it goes, with a live dashboard that residents can track. Pennsylvania reports 85% of its funding, per an opioid settlement tracker document.

In the Commonwealth, 70% of opioid settlement funds go to a community abatement program overseen by the Pennsylvania Opioid Misuse and Addiction Abatement Trust. Its advisory board is made up of lawmakers, county commissioners and behavioral health experts. The 30% of remaining funds goes into separate accounts, not all of which require public reporting of expenditures.

Advertise with us

The trust announced Sept. 1 that it would disburse an additional $6 million to Allegheny County from various settlements, placing Allegheny County in the top three in the state receiving settlement funds.

“[A]t the end of the day, making sure we continue to work toward a solution and direct any and all resources available to us is paramount,” said Sen. Christine Tartaglione, D-Philadelphia, who is on the trust’s advisory board and has co-sponsored opioid-related bills. With the fate of the Purdue Pharma bankruptcy unknown, she declined to speculate about the impact of the blocked funding but stressed the importance of settlement money.

“Any resources we can put toward addressing the opioid crisis are crucial and obviously greatly needed,” she said in an email, adding that “any dollar we can use toward solving the addiction crisis is vital.”

Brett Hambright, press secretary for the state Office of the Attorney General, detailed in an email the breakdown of Pennsylvania counties receiving opioid settlement funds. Philadelphia County is receiving the largest chunk, 23%, of the total $1.07 billion, followed by Allegheny County with 11.5% and Delaware County with 6%. All 67 Pennsylvania counties are receiving funds, some only a fraction of a percent of the total.

According to the Allegheny County Opioid Settlement dashboard, the county has $8.4 million from settlement funds to spend. To date, the county has spent just over $3.6 million of it. Most has been spent on research, followed by the expansion of services for those seeking recovery, expanding access to treatment, harm reduction supplies and supporting people already in recovery.

Advertise with us

Allegheny County saw 620 opioid-related deaths in 2022.

Protestors outside the Department of Justice in December 2021. (Courtesy of Ed Bisch)

While the dashboard doesn’t specify which organizations have received money, the Post-Gazette confirmed that organizations have received opioid settlement funds from the county to expand telehealth services for those with substance use disorders, purchase Narcan and syringe service supplies, and support the work of emergency medical services, among other initiatives. Allegheny Health Network and UPMC Toxicology Telemedicine Bridge Clinic were among the organizations that received funding.

AHN spokesman William Toland said that the halting of the Sackler funds has no impact on the network at this time, because a check was never written and plans for spending haven’t been laid out.

Sarah Deist, a spokeswoman for UPMC Altoona, confirmed the hospital system had received a $770,000 grant from the trust to expand behavioral health services in its emergency department. She said it would involve “creating a specialty pod that will offer a calm and safe setting for patients needing mental health care,” and that the hospital is still in the early stages of planning the project.

Altoona resident Marianne Sinisi, whose son, Shawn, died of a fentanyl overdose in Pittsburgh in 2018, said she believes this kind of project is the wrong use for the funds.

Advertise with us

“What happens 72 hours after they [leave the hospital]?” she said. “What support do they have? That’s where the money should go, on the streets, doing something.”

Amid reports of staffing shortages at the hospital, she also worries that execution of such a program might not live up to its promise.

Ms. Deist responded that, upon discharge, patients are provided with referrals to behavioral health outpatient services, as well as counseling and medication if necessary.

“Outpatient follow-up care is important for predicting long-term recovery for people struggling with substance use disorder,” she said. “Post-discharge is a sensitive time, and we try to provide the warmest handoff as possible to make sure patients can access the care they need.”

Marianne Sinisi, of Altoona, whose son died of an overdose of heroin and fentanyl in 2018, wants victims of the opioid epidemic to help decide how the state should use more than $1 billion from a multi-state settlement with major pharmaceutical companies.(KFF Health News)

In Allegheny County, $226,467 from the settlement funds has been spent to date on services for those with opioid use disorders and co-occurring mental health conditions.

Advertise with us

Ms. Sinisi stressed the inclusion at the decision-making table of those impacted by the opioid crisis.

“If they’re going to be making these decisions with the money, I don’t want them to have it,” she said. “I want the victims to have it.”

Mr. Bisch also noted that the $6 billion from Purdue Pharma would have been distributed over 18 years, reducing up-front impact from the disbursements. Whatever happens with the additional money, he said he hopes the Supreme Court “does the right thing.”

To him, that means shutting down the bankruptcy deal. His opinion aligns with that of those who have claimed Purdue Pharma’s bankruptcy filing, in 2019, was a tactic to shield itself — and the Sackler family — from further liability. It’s a not-uncommon practice for large corporations.

Ed Bisch protests at a rally outside the Department of Justice in December 2021.(Courtesy of Ed Bisch)

Johnson & Johnson, for example, has twice filed for bankruptcy protection while facing thousands of lawsuits for its talcum baby powder, later linked to cancer.

Advertise with us

“The attempt to protect third parties through the bankruptcy of an enterprise is definitely not new. This issue has been controversial since the 1980s,” said Melissa Jacoby, a professor of law at the University of North Carolina who focuses on bankruptcy law. “Even in courts that have permitted the practice, judges have expressed concern that the practice has gone too far.”

Purdue Pharma, through a spokesperson, expressed dismay over the highest court’s pause on the bankruptcy deal after the Justice Department’s bankruptcy watchdog, the U.S. Trustee, filed the objection.

“We are confident in the legality of our nearly universally supported Plan of Reorganization, and optimistic that the Supreme Court will agree. Even so, we are disappointed that the U.S. Trustee, despite having no concrete interest in the outcome of this process, has been able to single-handedly delay billions of dollars in value that should be put to use for victim compensation, opioid crisis abatement for communities across the country, and overdose rescue medicines.”

When Gov. Josh Shapiro was Pennsylvania attorney general, he joined other states in suing Purdue Pharma. He noted in a 2021 statement that “the Sacklers have used bankruptcy as a shield for true accountability for their role in jet-fueling this epidemic that takes 13 lives a day in our Commonwealth,” and that this drove the collective of attorneys general to increase the settlement total from its initial $3 billion.

Ms. Sinisi said she doesn’t believe that progress to help those into recovery is quick enough, even with settlement money available. “It’s really frustrating,” she said. “We look at it and think, ‘What’s changing?’... People are fighting over [this money] when people are dying in the streets every single day.”

Hanna Webster: hwebster@post-gazette.com